Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E. M. Zola"'
Autor:
M. Shwer, K. P. Van Meurs, A. Lotze, S. Keeney, R. Cicco, J. McGowan, S. Denson, G. Knight, A. Thompson, W. Engle, K. B. Al-Mateen, R. Baker, E. Rider, P. Riedel, J. Gonzalez, C. Dothey, J. Sparks, E. Stork, S. St. Charles, G. Waterkotte, D. Hsiao, D. Kays, D. J. Rawlings, J. Ferlauto, D. Purohit, M. Keszler, D. Marsh, R. Miller, S. Pearlman, M. Magoon, J. Fasules, D. Stewart, W. Kanto, M. Maurer, J. H. Gunkel, M. Fernandes, H. Feick, E. M. Zola, M. Antunes, B. R. Mitchell, D. I. Bulas, R. A. Shalwitz, T. Weber, L. Parton, D. Sprague, B. Patel, J. Bhatia, M. Rodriguez, L. Salter, F. Murphey, W. Drummond, J. Gerdes
Publikováno v:
The Journal of Pediatrics. 132:40-47
Objective: The purpose of this study was to determine whether surfactant (beractant) administration to term newborns in respiratory failure and at risk for requiring extracorporeal membrane oxygenation (ECMO) treatment would significantly reduce the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ac3dce7c99bfdbaff3acf2b138ef31d
https://doi.org/10.1016/s0022-3476(98)70482-2
https://doi.org/10.1016/s0022-3476(98)70482-2
Autor:
J H Gunkel, B R Mitchell, N G DeMarco, A M Overbach, B T Nagle, E M Zola, A J Gold, G A Henwood
Publikováno v:
Pediatrics. 91:546-551
From September 1989 through July 1991, before commercial availability, Survanta (beractant intratracheal suspension), a modified bovine-derived surfactant used for prevention and treatment of neonatal respiratory distress syndrome, was made available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50f80dca860acfd7ce541bca678dd91b
https://doi.org/10.1542/peds.91.3.546
https://doi.org/10.1542/peds.91.3.546
Publikováno v:
The Journal of pediatrics. 132(1)
The purpose of this study was to determine whether surfactant (beractant) administration to term newborns in respiratory failure and at risk for requiring extracorporeal membrane oxygenation (ECMO) treatment would significantly reduce the incidence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fca556729fe2f4f644011e0a302cfc4
https://pubmed.ncbi.nlm.nih.gov/10431251
https://pubmed.ncbi.nlm.nih.gov/10431251
Autor:
E M, Zola, A M, Overbach, J H, Gunkel, B R, Mitchell, B T, Nagle, N G, DeMarco, G A, Henwood, A J, Gold
Publikováno v:
Pediatrics. 91(3)
From September 1989 through July 1991, before commercial availability, Survanta (beractant intratracheal suspension), a modified bovine-derived surfactant used for prevention and treatment of neonatal respiratory distress syndrome, was made available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c201bf97e4fe393b0d35d25c6abbae55
https://pubmed.ncbi.nlm.nih.gov/8441557
https://pubmed.ncbi.nlm.nih.gov/8441557
Autor:
E M, Zola
Publikováno v:
Clinical pharmacy. 11(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7298eebe8c4be595539a92a28c7e4f57
https://pubmed.ncbi.nlm.nih.gov/1773577
https://pubmed.ncbi.nlm.nih.gov/1773577
